THE LATEST | CANADASince late 2022, bad news in biotech has been nearly inescapable: flopped trials, slashed drug pipelines, bankruptcies and stock price collapses that destroyed billions of dollars in value. It’s all led to layoffs, plunging thousands of workers into unemployment amid a competitive job market…
Layoffs, shutdowns and billions up in smoke. What’s wrong with Bay Area biotech?
Subscribe
Login
0 Comments
Oldest